The global market for Guanylate Cyclase-C Agonists was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Constipation associated with irritable bowel syndrome (IBS) and chronic cons1tipation of unclear cause (idiopathic constipation) in adults are treated with guanylate cyclase-C agonists. IBS is characterized by stomach pain or cramps, bloating, and infrequent or difficult bowel movements. Guanylate cyclase-C agonists are prescription pharmaceuticals that can be taken alone or in combination with other drugs.

North American market for Guanylate Cyclase-C Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Guanylate Cyclase-C Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Guanylate Cyclase-C Agonists include Bayer, MSD, AstraZeneca, Synergy, Salix Pharmaceuticals, UPM Pharmaceuticals,Inc, Ironwood, Luoxin Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Guanylate Cyclase-C Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Guanylate Cyclase-C Agonists.

The Guanylate Cyclase-C Agonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Guanylate Cyclase-C Agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Guanylate Cyclase-C Agonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Guanylate Cyclase-C Agonists Market Report

Report Metric	Details
Report Name	Guanylate Cyclase-C Agonists Market
Segment by Type	Plecanatide Linaclotide
Segment by Application	Irritable Bowel Syndrome Chronic Idiopathic Constipation Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bayer, MSD, AstraZeneca, Synergy, Salix Pharmaceuticals, UPM Pharmaceuticals,Inc, Ironwood, Luoxin Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Guanylate Cyclase-C Agonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Guanylate Cyclase-C Agonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Guanylate Cyclase-C Agonists Market report?

Ans: The main players in the Guanylate Cyclase-C Agonists Market are Bayer, MSD, AstraZeneca, Synergy, Salix Pharmaceuticals, UPM Pharmaceuticals,Inc, Ironwood, Luoxin Pharmaceutical

What are the Application segmentation covered in the Guanylate Cyclase-C Agonists Market report?

Ans: The Applications covered in the Guanylate Cyclase-C Agonists Market report are Irritable Bowel Syndrome, Chronic Idiopathic Constipation, Other

What are the Type segmentation covered in the Guanylate Cyclase-C Agonists Market report?

Ans: The Types covered in the Guanylate Cyclase-C Agonists Market report are Plecanatide, Linaclotide

1 Guanylate Cyclase-C Agonists Market Overview

1.1 Product Definition

1.2 Guanylate Cyclase-C Agonists by Type

1.2.1 Global Guanylate Cyclase-C Agonists Market Value Comparison by Type (2024 VS 2031)

1.2.2 Plecanatide

1.2.3 Linaclotide

1.3 Guanylate Cyclase-C Agonists by Application

1.3.1 Global Guanylate Cyclase-C Agonists Market Value by Application (2024 VS 2031)

1.3.2 Irritable Bowel Syndrome

1.3.3 Chronic Idiopathic Constipation

1.3.4 Other

1.4 Global Guanylate Cyclase-C Agonists Market Size Estimates and Forecasts

1.4.1 Global Guanylate Cyclase-C Agonists Revenue 2020-2031

1.4.2 Global Guanylate Cyclase-C Agonists Sales 2020-2031

1.4.3 Global Guanylate Cyclase-C Agonists Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Guanylate Cyclase-C Agonists Market Competition by Manufacturers

2.1 Global Guanylate Cyclase-C Agonists Sales Market Share by Manufacturers (2020-2025)

2.2 Global Guanylate Cyclase-C Agonists Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Guanylate Cyclase-C Agonists Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Guanylate Cyclase-C Agonists, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Guanylate Cyclase-C Agonists, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Guanylate Cyclase-C Agonists, Product Type & Application

2.7 Global Key Manufacturers of Guanylate Cyclase-C Agonists, Date of Enter into This Industry

2.8 Global Guanylate Cyclase-C Agonists Market Competitive Situation and Trends

2.8.1 Global Guanylate Cyclase-C Agonists Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Guanylate Cyclase-C Agonists Players Market Share by Revenue

2.8.3 Global Guanylate Cyclase-C Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Guanylate Cyclase-C Agonists Market Scenario by Region

3.1 Global Guanylate Cyclase-C Agonists Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Guanylate Cyclase-C Agonists Sales by Region: 2020-2031

3.2.1 Global Guanylate Cyclase-C Agonists Sales by Region: 2020-2025

3.2.2 Global Guanylate Cyclase-C Agonists Sales by Region: 2026-2031

3.3 Global Guanylate Cyclase-C Agonists Revenue by Region: 2020-2031

3.3.1 Global Guanylate Cyclase-C Agonists Revenue by Region: 2020-2025

3.3.2 Global Guanylate Cyclase-C Agonists Revenue by Region: 2026-2031

3.4 North America Guanylate Cyclase-C Agonists Market Facts & Figures by Country

3.4.1 North America Guanylate Cyclase-C Agonists Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Guanylate Cyclase-C Agonists Sales by Country (2020-2031)

3.4.3 North America Guanylate Cyclase-C Agonists Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Guanylate Cyclase-C Agonists Market Facts & Figures by Country

3.5.1 Europe Guanylate Cyclase-C Agonists Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Guanylate Cyclase-C Agonists Sales by Country (2020-2031)

3.5.3 Europe Guanylate Cyclase-C Agonists Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Guanylate Cyclase-C Agonists Market Facts & Figures by Region

3.6.1 Asia Pacific Guanylate Cyclase-C Agonists Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Guanylate Cyclase-C Agonists Sales by Region (2020-2031)

3.6.3 Asia Pacific Guanylate Cyclase-C Agonists Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Guanylate Cyclase-C Agonists Market Facts & Figures by Country

3.7.1 Latin America Guanylate Cyclase-C Agonists Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Guanylate Cyclase-C Agonists Sales by Country (2020-2031)

3.7.3 Latin America Guanylate Cyclase-C Agonists Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Guanylate Cyclase-C Agonists Market Facts & Figures by Country

3.8.1 Middle East and Africa Guanylate Cyclase-C Agonists Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Guanylate Cyclase-C Agonists Sales by Country (2020-2031)

3.8.3 Middle East and Africa Guanylate Cyclase-C Agonists Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Guanylate Cyclase-C Agonists Sales by Type (2020-2031)

4.1.1 Global Guanylate Cyclase-C Agonists Sales by Type (2020-2025)

4.1.2 Global Guanylate Cyclase-C Agonists Sales by Type (2026-2031)

4.1.3 Global Guanylate Cyclase-C Agonists Sales Market Share by Type (2020-2031)

4.2 Global Guanylate Cyclase-C Agonists Revenue by Type (2020-2031)

4.2.1 Global Guanylate Cyclase-C Agonists Revenue by Type (2020-2025)

4.2.2 Global Guanylate Cyclase-C Agonists Revenue by Type (2026-2031)

4.2.3 Global Guanylate Cyclase-C Agonists Revenue Market Share by Type (2020-2031)

4.3 Global Guanylate Cyclase-C Agonists Price by Type (2020-2031)

5 Segment by Application

5.1 Global Guanylate Cyclase-C Agonists Sales by Application (2020-2031)

5.1.1 Global Guanylate Cyclase-C Agonists Sales by Application (2020-2025)

5.1.2 Global Guanylate Cyclase-C Agonists Sales by Application (2026-2031)

5.1.3 Global Guanylate Cyclase-C Agonists Sales Market Share by Application (2020-2031)

5.2 Global Guanylate Cyclase-C Agonists Revenue by Application (2020-2031)

5.2.1 Global Guanylate Cyclase-C Agonists Revenue by Application (2020-2025)

5.2.2 Global Guanylate Cyclase-C Agonists Revenue by Application (2026-2031)

5.2.3 Global Guanylate Cyclase-C Agonists Revenue Market Share by Application (2020-2031)

5.3 Global Guanylate Cyclase-C Agonists Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Bayer

6.1.1 Bayer Company Information

6.1.2 Bayer Description and Business Overview

6.1.3 Bayer Guanylate Cyclase-C Agonists Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Bayer Guanylate Cyclase-C Agonists Product Portfolio

6.1.5 Bayer Recent Developments/Updates

6.2 MSD

6.2.1 MSD Company Information

6.2.2 MSD Description and Business Overview

6.2.3 MSD Guanylate Cyclase-C Agonists Sales, Revenue and Gross Margin (2020-2025)

6.2.4 MSD Guanylate Cyclase-C Agonists Product Portfolio

6.2.5 MSD Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Company Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Guanylate Cyclase-C Agonists Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AstraZeneca Guanylate Cyclase-C Agonists Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Synergy

6.4.1 Synergy Company Information

6.4.2 Synergy Description and Business Overview

6.4.3 Synergy Guanylate Cyclase-C Agonists Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Synergy Guanylate Cyclase-C Agonists Product Portfolio

6.4.5 Synergy Recent Developments/Updates

6.5 Salix Pharmaceuticals

6.5.1 Salix Pharmaceuticals Company Information

6.5.2 Salix Pharmaceuticals Description and Business Overview

6.5.3 Salix Pharmaceuticals Guanylate Cyclase-C Agonists Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Salix Pharmaceuticals Guanylate Cyclase-C Agonists Product Portfolio

6.5.5 Salix Pharmaceuticals Recent Developments/Updates

6.6 UPM Pharmaceuticals,Inc

6.6.1 UPM Pharmaceuticals,Inc Company Information

6.6.2 UPM Pharmaceuticals,Inc Description and Business Overview

6.6.3 UPM Pharmaceuticals,Inc Guanylate Cyclase-C Agonists Sales, Revenue and Gross Margin (2020-2025)

6.6.4 UPM Pharmaceuticals,Inc Guanylate Cyclase-C Agonists Product Portfolio

6.6.5 UPM Pharmaceuticals,Inc Recent Developments/Updates

6.7 Ironwood

6.7.1 Ironwood Company Information

6.7.2 Ironwood Description and Business Overview

6.7.3 Ironwood Guanylate Cyclase-C Agonists Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Ironwood Guanylate Cyclase-C Agonists Product Portfolio

6.7.5 Ironwood Recent Developments/Updates

6.8 Luoxin Pharmaceutical

6.8.1 Luoxin Pharmaceutical Company Information

6.8.2 Luoxin Pharmaceutical Description and Business Overview

6.8.3 Luoxin Pharmaceutical Guanylate Cyclase-C Agonists Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Luoxin Pharmaceutical Guanylate Cyclase-C Agonists Product Portfolio

6.8.5 Luoxin Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Guanylate Cyclase-C Agonists Industry Chain Analysis

7.2 Guanylate Cyclase-C Agonists Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Guanylate Cyclase-C Agonists Production Mode & Process Analysis

7.4 Guanylate Cyclase-C Agonists Sales and Marketing

7.4.1 Guanylate Cyclase-C Agonists Sales Channels

7.4.2 Guanylate Cyclase-C Agonists Distributors

7.5 Guanylate Cyclase-C Agonists Customer Analysis

8 Guanylate Cyclase-C Agonists Market Dynamics

8.1 Guanylate Cyclase-C Agonists Industry Trends

8.2 Guanylate Cyclase-C Agonists Market Drivers

8.3 Guanylate Cyclase-C Agonists Market Challenges

8.4 Guanylate Cyclase-C Agonists Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Salix Pharmaceuticals

UPM Pharmaceuticals Inc.

Ironwood

Luoxin Pharmaceutical

List of Tables

Table 1. Global Guanylate Cyclase-C Agonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Guanylate Cyclase-C Agonists Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Guanylate Cyclase-C Agonists Market Competitive Situation by Manufacturers in 2024

Table 4. Global Guanylate Cyclase-C Agonists Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Guanylate Cyclase-C Agonists Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Guanylate Cyclase-C Agonists Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Guanylate Cyclase-C Agonists Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Guanylate Cyclase-C Agonists Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Guanylate Cyclase-C Agonists, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Guanylate Cyclase-C Agonists, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Guanylate Cyclase-C Agonists, Product Type & Application

Table 12. Global Key Manufacturers of Guanylate Cyclase-C Agonists, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Guanylate Cyclase-C Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guanylate Cyclase-C Agonists as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Guanylate Cyclase-C Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Guanylate Cyclase-C Agonists Sales by Region (2020-2025) & (K Units)

Table 18. Global Guanylate Cyclase-C Agonists Sales Market Share by Region (2020-2025)

Table 19. Global Guanylate Cyclase-C Agonists Sales by Region (2026-2031) & (K Units)

Table 20. Global Guanylate Cyclase-C Agonists Sales Market Share by Region (2026-2031)

Table 21. Global Guanylate Cyclase-C Agonists Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Guanylate Cyclase-C Agonists Revenue Market Share by Region (2020-2025)

Table 23. Global Guanylate Cyclase-C Agonists Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Guanylate Cyclase-C Agonists Revenue Market Share by Region (2026-2031)

Table 25. North America Guanylate Cyclase-C Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Guanylate Cyclase-C Agonists Sales by Country (2020-2025) & (K Units)

Table 27. North America Guanylate Cyclase-C Agonists Sales by Country (2026-2031) & (K Units)

Table 28. North America Guanylate Cyclase-C Agonists Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Guanylate Cyclase-C Agonists Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Guanylate Cyclase-C Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Guanylate Cyclase-C Agonists Sales by Country (2020-2025) & (K Units)

Table 32. Europe Guanylate Cyclase-C Agonists Sales by Country (2026-2031) & (K Units)

Table 33. Europe Guanylate Cyclase-C Agonists Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Guanylate Cyclase-C Agonists Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Guanylate Cyclase-C Agonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Guanylate Cyclase-C Agonists Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Guanylate Cyclase-C Agonists Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Guanylate Cyclase-C Agonists Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Guanylate Cyclase-C Agonists Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Guanylate Cyclase-C Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Guanylate Cyclase-C Agonists Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Guanylate Cyclase-C Agonists Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Guanylate Cyclase-C Agonists Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Guanylate Cyclase-C Agonists Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Guanylate Cyclase-C Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Guanylate Cyclase-C Agonists Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Guanylate Cyclase-C Agonists Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Guanylate Cyclase-C Agonists Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Guanylate Cyclase-C Agonists Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Guanylate Cyclase-C Agonists Sales (K Units) by Type (2020-2025)

Table 51. Global Guanylate Cyclase-C Agonists Sales (K Units) by Type (2026-2031)

Table 52. Global Guanylate Cyclase-C Agonists Sales Market Share by Type (2020-2025)

Table 53. Global Guanylate Cyclase-C Agonists Sales Market Share by Type (2026-2031)

Table 54. Global Guanylate Cyclase-C Agonists Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Guanylate Cyclase-C Agonists Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Guanylate Cyclase-C Agonists Revenue Market Share by Type (2020-2025)

Table 57. Global Guanylate Cyclase-C Agonists Revenue Market Share by Type (2026-2031)

Table 58. Global Guanylate Cyclase-C Agonists Price (US$/Unit) by Type (2020-2025)

Table 59. Global Guanylate Cyclase-C Agonists Price (US$/Unit) by Type (2026-2031)

Table 60. Global Guanylate Cyclase-C Agonists Sales (K Units) by Application (2020-2025)

Table 61. Global Guanylate Cyclase-C Agonists Sales (K Units) by Application (2026-2031)

Table 62. Global Guanylate Cyclase-C Agonists Sales Market Share by Application (2020-2025)

Table 63. Global Guanylate Cyclase-C Agonists Sales Market Share by Application (2026-2031)

Table 64. Global Guanylate Cyclase-C Agonists Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Guanylate Cyclase-C Agonists Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Guanylate Cyclase-C Agonists Revenue Market Share by Application (2020-2025)

Table 67. Global Guanylate Cyclase-C Agonists Revenue Market Share by Application (2026-2031)

Table 68. Global Guanylate Cyclase-C Agonists Price (US$/Unit) by Application (2020-2025)

Table 69. Global Guanylate Cyclase-C Agonists Price (US$/Unit) by Application (2026-2031)

Table 70. Bayer Company Information

Table 71. Bayer Description and Business Overview

Table 72. Bayer Guanylate Cyclase-C Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Bayer Guanylate Cyclase-C Agonists Product

Table 74. Bayer Recent Developments/Updates

Table 75. MSD Company Information

Table 76. MSD Description and Business Overview

Table 77. MSD Guanylate Cyclase-C Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. MSD Guanylate Cyclase-C Agonists Product

Table 79. MSD Recent Developments/Updates

Table 80. AstraZeneca Company Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Guanylate Cyclase-C Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. AstraZeneca Guanylate Cyclase-C Agonists Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Synergy Company Information

Table 86. Synergy Description and Business Overview

Table 87. Synergy Guanylate Cyclase-C Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Synergy Guanylate Cyclase-C Agonists Product

Table 89. Synergy Recent Developments/Updates

Table 90. Salix Pharmaceuticals Company Information

Table 91. Salix Pharmaceuticals Description and Business Overview

Table 92. Salix Pharmaceuticals Guanylate Cyclase-C Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Salix Pharmaceuticals Guanylate Cyclase-C Agonists Product

Table 94. Salix Pharmaceuticals Recent Developments/Updates

Table 95. UPM Pharmaceuticals,Inc Company Information

Table 96. UPM Pharmaceuticals,Inc Description and Business Overview

Table 97. UPM Pharmaceuticals,Inc Guanylate Cyclase-C Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. UPM Pharmaceuticals,Inc Guanylate Cyclase-C Agonists Product

Table 99. UPM Pharmaceuticals,Inc Recent Developments/Updates

Table 100. Ironwood Company Information

Table 101. Ironwood Description and Business Overview

Table 102. Ironwood Guanylate Cyclase-C Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Ironwood Guanylate Cyclase-C Agonists Product

Table 104. Ironwood Recent Developments/Updates

Table 105. Luoxin Pharmaceutical Company Information

Table 106. Luoxin Pharmaceutical Description and Business Overview

Table 107. Luoxin Pharmaceutical Guanylate Cyclase-C Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Luoxin Pharmaceutical Guanylate Cyclase-C Agonists Product

Table 109. Luoxin Pharmaceutical Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Guanylate Cyclase-C Agonists Distributors List

Table 113. Guanylate Cyclase-C Agonists Customers List

Table 114. Guanylate Cyclase-C Agonists Market Trends

Table 115. Guanylate Cyclase-C Agonists Market Drivers

Table 116. Guanylate Cyclase-C Agonists Market Challenges

Table 117. Guanylate Cyclase-C Agonists Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Guanylate Cyclase-C Agonists

Figure 2. Global Guanylate Cyclase-C Agonists Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Guanylate Cyclase-C Agonists Market Share by Type: 2024 & 2031

Figure 4. Plecanatide Product Picture

Figure 5. Linaclotide Product Picture

Figure 6. Global Guanylate Cyclase-C Agonists Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Guanylate Cyclase-C Agonists Market Share by Application: 2024 & 2031

Figure 8. Irritable Bowel Syndrome

Figure 9. Chronic Idiopathic Constipation

Figure 10. Other

Figure 11. Global Guanylate Cyclase-C Agonists Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Guanylate Cyclase-C Agonists Market Size (2020-2031) & (US$ Million)

Figure 13. Global Guanylate Cyclase-C Agonists Sales (2020-2031) & (K Units)

Figure 14. Global Guanylate Cyclase-C Agonists Average Price (US$/Unit) & (2020-2031)

Figure 15. Guanylate Cyclase-C Agonists Report Years Considered

Figure 16. Guanylate Cyclase-C Agonists Sales Share by Manufacturers in 2024

Figure 17. Global Guanylate Cyclase-C Agonists Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Guanylate Cyclase-C Agonists Players: Market Share by Revenue in Guanylate Cyclase-C Agonists in 2024

Figure 19. Guanylate Cyclase-C Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Guanylate Cyclase-C Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Guanylate Cyclase-C Agonists Sales Market Share by Country (2020-2031)

Figure 22. North America Guanylate Cyclase-C Agonists Revenue Market Share by Country (2020-2031)

Figure 23. United States Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Guanylate Cyclase-C Agonists Sales Market Share by Country (2020-2031)

Figure 26. Europe Guanylate Cyclase-C Agonists Revenue Market Share by Country (2020-2031)

Figure 27. Germany Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Guanylate Cyclase-C Agonists Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Guanylate Cyclase-C Agonists Revenue Market Share by Region (2020-2031)

Figure 34. China Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Guanylate Cyclase-C Agonists Sales Market Share by Country (2020-2031)

Figure 42. Latin America Guanylate Cyclase-C Agonists Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Guanylate Cyclase-C Agonists Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Guanylate Cyclase-C Agonists Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Guanylate Cyclase-C Agonists Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Guanylate Cyclase-C Agonists by Type (2020-2031)

Figure 52. Global Revenue Market Share of Guanylate Cyclase-C Agonists by Type (2020-2031)

Figure 53. Global Guanylate Cyclase-C Agonists Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of Guanylate Cyclase-C Agonists by Application (2020-2031)

Figure 55. Global Revenue Market Share of Guanylate Cyclase-C Agonists by Application (2020-2031)

Figure 56. Global Guanylate Cyclase-C Agonists Price (US$/Unit) by Application (2020-2031)

Figure 57. Guanylate Cyclase-C Agonists Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions